Ronald Silver insider trades: Ironwood Pharmaceuticals (IRWD) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ronald reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | IRWD | ↓ Sell | 127,890 | $4.52 | $578K | Direct | Jul 9, 2026 (2d) |
| Feb 24, 2026 | IRWD | ↓ Sell | 24,173 | $3.73 | $90K | Direct | Feb 25, 2026 (1d) |
| Jan 5, 2026 | IRWD | ↓ Sell | 35,416 | $4.60 | $163K | Direct | Jan 7, 2026 (2d) |
| Aug 11, 2025 | IRWD | ↓ Sell | 2,846 | $0.84 | $2K | Direct | Aug 13, 2025 (2d) |
| Feb 10, 2025 | IRWD | ↓ Sell | 12,048 | $1.76 | $21K | Direct | Feb 12, 2025 (2d) |
| Aug 12, 2024 | IRWD | ↓ Sell | 3,107 | $4.27 | $13K | Direct | Aug 14, 2024 (2d) |
| Feb 12, 2024 | IRWD | ↓ Sell | 7,908 | $15.24 | $121K | Direct | Feb 14, 2024 (2d) |
| Aug 14, 2023 | IRWD | ↓ Sell | 1,976 | $10.04 | $20K | Direct | Aug 16, 2023 (2d) |
| Feb 28, 2023 | IRWD | ↓ Sell | 5,978 | $11.36 | $68K | Direct | Mar 1, 2023 (1d) |
| Nov 21, 2022 | IRWD | ↓ Sell | 682 | $11.56 | $8K | Direct | Nov 23, 2022 (2d) |
| Aug 15, 2022 | IRWD | ↓ Sell | 2,014 | $11.77 | $24K | Direct | Aug 17, 2022 (2d) |
| May 23, 2022 | IRWD | ↓ Sell | 120 | $11.50 | $1K | Direct | May 25, 2022 (2d) |
| Mar 24, 2022 | IRWD | ↓ Sell | 3,031 | $12.75 | $39K | Direct | Mar 25, 2022 (1d) |
| Feb 28, 2022 | IRWD | ↓ Sell | 2,238 | $10.77 | $24K | Direct | Mar 2, 2022 (2d) |
| Nov 23, 2021 | IRWD | ↓ Sell | 1,462 | $11.58 | $17K | Direct | Nov 24, 2021 (1d) |
| Aug 16, 2021 | IRWD | ↓ Sell | 567 | $13.48 | $8K | Direct | Aug 18, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IRWD insiders
Open-market trades in the last 12 months
About Ronald Silver's insider trades
Ronald Silver is Pfo & Pao at Ironwood Pharmaceuticals (IRWD). Since Aug 16, 2021, Ronald has reported no open-market purchases and 16 sales worth $1.2M on SEC Form 4. In the last 12 months: 3 sales ($831K).
Their filings also include grants and awards (8 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IRWD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.